Actuate Therapeutics Inc(ACTU)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ACTU Actuate Therapeutics Inc

交易中 03-23 10:17:04 EDT

2.35

+0.00

0.00%

最高2.40	最低2.35	成交量4,133
今开2.40	昨收2.35	日振幅2.13%
总市值5,462万	流通市值2,181万	总股本2,324万
成交额9,830	换手率0.04%	流通股本928.03万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ACTU","market":"US","secType":"STK","nameCN":"Actuate Therapeutics Inc","latestPrice":2.35,"timestamp":1774275247965,"preClose":2.35,"halted":0,"volume":4133,"delay":0,"changeRate":0,"floatShares":9280300,"shares":23243328,"eps":-1.204351,"marketStatus":"交易中","change":0,"latestTime":"03-23 10:17:04 EDT","open":2.4,"high":2.4,"low":2.35,"amount":9830.2772651,"amplitude":0.021277,"askPrice":2.39,"askSize":300,"bidPrice":2.3,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.204351,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774296000000},"marketStatusCode":2,"adr":0,"listingDate":1723521600000,"exchange":"NASDAQ","adjPreClose":2.35,"postHourTrading":{"tag":"盘后","latestPrice":2.35,"preClose":2.35,"latestTime":"18:03 EDT","volume":13227,"amount":31083.45,"timestamp":1774044221415,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.335318},"requestUrl":"/m/hq/s/ACTU","defaultTab":"news","newsList":[{"id":"1147801279","title":"Actuate Therapeutics启动战略研究计划，探索Elraglusib与Ras抑制剂的联合疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1147801279","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147801279?lang=zh_cn&edition=full","pubTime":"2026-03-09 20:45","pubTimestamp":1773060318,"startTime":"0","endTime":"0","summary":"生物制药公司Actuate Therapeutics Inc宣布，已正式启动一项战略研究计划。该计划的核心目标是评估其核心候选药物Elraglusib与Ras抑制剂联合使用的潜力。这项研究旨在探索新的治疗途径，为相关疾病领域的患者带来新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACTU","BK4139"],"gpt_icon":0},{"id":"1126589843","title":"Actuate Therapeutics宣布拓展临床管线计划，将Elraglusib片剂推进至难治性癌症的1/2期临床项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1126589843","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126589843?lang=zh_cn&edition=full","pubTime":"2026-01-21 21:46","pubTimestamp":1769003178,"startTime":"0","endTime":"0","summary":"生物制药公司Actuate Therapeutics Inc  近日披露了其临床开发战略的重大进展。公司计划显著拓展其研发管线，核心举措是将旗下在研药物Elraglusib片剂正式推入一项针对难治性癌症的1/2期临床研究项目。Elraglusib作为一种口服片剂，其针对难治性癌症的临床开发进入新阶段，旨在为现有治疗方案效果不佳的患者群体探索新的治疗可能性。此次管线拓展凸显了Actuate Therapeutics致力于通过创新疗法解决未满足医疗需求的决心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACTU","BK4139"],"gpt_icon":0},{"id":"1158074528","title":"Actuate Therapeutics宣布难治性儿科癌症一期试验取得积极患者成果","url":"https://stock-news.laohu8.com/highlight/detail?id=1158074528","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158074528?lang=zh_cn&edition=full","pubTime":"2026-01-06 21:47","pubTimestamp":1767707249,"startTime":"0","endTime":"0","summary":"生物制药公司Actuate Therapeutics Inc公布了其针对难治性儿科癌症的一期临床试验的积极数据。试验结果显示，在治疗那些常规疗法效果不佳的棘手儿科癌症病例中，取得了令人鼓舞的患者预后成果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACTU"],"gpt_icon":0},{"id":"1130129052","title":"Actuate Therapeutics Inc - 与B. Riley和Craig-Hallum签订市场发行销售协议 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1130129052","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130129052?lang=zh_cn&edition=full","pubTime":"2025-11-29 06:24","pubTimestamp":1764368648,"startTime":"0","endTime":"0","summary":"Actuate Therapeutics Inc - 与B. Riley和Craig-Hallum签订市场发行销售协议 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACTU","BK4139"],"gpt_icon":0},{"id":"1103136637","title":"Actuate Therapeutics向FDA提交更新临床数据包 为未来几个月与监管机构的互动做准备","url":"https://stock-news.laohu8.com/highlight/detail?id=1103136637","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103136637?lang=zh_cn&edition=full","pubTime":"2025-09-22 20:45","pubTimestamp":1758545120,"startTime":"0","endTime":"0","summary":"Actuate Therapeutics Inc近日向美国食品药品监督管理局(FDA)提交了更新的临床数据包，此举旨在为公司计划在未来几个月内与FDA和欧洲药品管理局(EMA)进行的监管互动提供支持。\n这一举措表明该公司正在积极推进其药物开发进程，通过向监管机构提供最新的临床试验数据，为后续的监管审查和批准流程奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACTU"],"gpt_icon":0},{"id":"2518627975","title":"Actuate Therapeutics, Inc.盘中异动 急速拉升6.12%报7.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518627975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518627975?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:33","pubTimestamp":1741613586,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时33分，Actuate Therapeutics, Inc.股票出现波动，股价大幅拉升6.12%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2057.25%、403.96%、61.18%，振幅较大的相关个股有Akero Therapeutics, Inc.、Xencor, Inc.、Seer, Inc.，振幅分别为99.91%、99.13%、98.72%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021330796403636&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021330796403636&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACTU","LENZ","BK4139"],"gpt_icon":0},{"id":"2517937811","title":"Actuate Therapeutics, Inc.盘中异动 快速下挫5.29%报6.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517937811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517937811?lang=zh_cn&edition=full","pubTime":"2025-03-07 01:29","pubTimestamp":1741282156,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日01时29分，Actuate Therapeutics, Inc.股票出现波动，股价急速跳水5.29%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.77%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307012917963c6d1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307012917963c6d1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ACTU","BK4139"],"gpt_icon":0},{"id":"2516673655","title":"Actuate Therapeutics, Inc.盘中异动 临近午盘急速下跌9.21%报6.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516673655","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516673655?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:31","pubTimestamp":1741019501,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日00时31分，Actuate Therapeutics, Inc.股票出现波动，股价快速下挫9.21%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304003141abe6593c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304003141abe6593c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACTU","LENZ"],"gpt_icon":0},{"id":"2514869643","title":"Actuate Therapeutics, Inc.盘中异动 股价大涨9.30%报7.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514869643","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514869643?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:48","pubTimestamp":1740667706,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时48分，Actuate Therapeutics, Inc.股票出现异动，股价大幅上涨9.30%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.82%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722482798951393&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722482798951393&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACTU","BK4139","LENZ"],"gpt_icon":0},{"id":"2514568488","title":"Actuate Therapeutics, Inc.盘中异动 股价大涨7.72%报7.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514568488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514568488?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:38","pubTimestamp":1740580701,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时38分，Actuate Therapeutics, Inc.股票出现波动，股价急速拉升7.72%。截至发稿，该股报7.61美元/股，成交量768股，换手率0.00%，振幅0.00%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.57%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223821a254f84e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223821a254f84e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ACTU"],"gpt_icon":0},{"id":"2513361778","title":"Actuate Therapeutics, Inc.盘中异动 大幅下挫5.16%报7.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513361778","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513361778?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:07","pubTimestamp":1740409622,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时07分，Actuate Therapeutics, Inc.股票出现异动，股价快速下挫5.16%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Pepgen Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为165.25%、72.03%、25.97%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、42.86%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230702a2521d54&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230702a2521d54&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACTU","LENZ","BK4139"],"gpt_icon":0},{"id":"2511669733","title":"Actuate Therapeutics, Inc.盘中异动 早盘急速跳水5.56%报7.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511669733","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511669733?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:53","pubTimestamp":1739548389,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时53分，Actuate Therapeutics, Inc.股票出现异动，股价急速下跌5.56%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.76%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021423530998859cd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021423530998859cd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACTU","LENZ"],"gpt_icon":0},{"id":"2510360403","title":"Actuate Therapeutics, Inc.盘中异动 早盘急速跳水5.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510360403","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510360403?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:56","pubTimestamp":1739289410,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时56分，Actuate Therapeutics, Inc.股票出现波动，股价快速跳水5.94%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.77%。其相关个股中，Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Dominari Holdings Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2752.22%、1190.45%、390.00%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为58.60%、57.43%、40.87%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211235650a2420e2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211235650a2420e2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACTU","LENZ"],"gpt_icon":0},{"id":"2508140788","title":"Actuate Therapeutics, Inc.盘中异动 早盘大幅拉升5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508140788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508140788?lang=zh_cn&edition=full","pubTime":"2025-02-04 00:10","pubTimestamp":1738599013,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日00时10分，Actuate Therapeutics, Inc.股票出现异动，股价急速上涨5.32%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为576.67%、440.17%、362.89%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Briacell Therapeutics Corp.，振幅分别为167.11%、75.23%、63.65%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204001013a2381df3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204001013a2381df3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ACTU","BK4139"],"gpt_icon":0},{"id":"2507770961","title":"Actuate Therapeutics, Inc.盘中异动 早盘急速拉升7.36%报9.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507770961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507770961?lang=zh_cn&edition=full","pubTime":"2025-01-31 23:39","pubTimestamp":1738337967,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日23时39分，Actuate Therapeutics, Inc.股票出现异动，股价快速拉升7.36%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131233927a2354f37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131233927a2354f37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ACTU","BK4139"],"gpt_icon":0},{"id":"2506306476","title":"Actuate Therapeutics, Inc.盘中异动 早盘股价大涨6.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506306476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506306476?lang=zh_cn&edition=full","pubTime":"2025-01-27 23:18","pubTimestamp":1737991096,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日23时18分，Actuate Therapeutics, Inc.股票出现异动，股价急速拉升6.82%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.99%。其相关个股中，Akero Therapeutics, Inc.、Onconetix, Inc.、89Bio, Inc.涨幅较大，Onconetix, Inc.、Evaxion Biotech As、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1735.73%、191.22%、170.94%，振幅较大的相关个股有Onconetix, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Immatics N V C/Wts 01/07/2025 ，振幅分别为85.35%、65.16%、61.25%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127231816a231749c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127231816a231749c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACTU","BK4139","LENZ"],"gpt_icon":0},{"id":"2505869022","title":"Actuate Therapeutics, Inc.盘中异动 早盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505869022","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505869022?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:36","pubTimestamp":1737729360,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时36分，Actuate Therapeutics, Inc.股票出现波动，股价大幅跳水5.09%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223600abb74f92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223600abb74f92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACTU","BK4139","LENZ"],"gpt_icon":0},{"id":"2505277440","title":"Actuate Therapeutics, Inc.盘中异动 下午盘股价大涨5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505277440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505277440?lang=zh_cn&edition=full","pubTime":"2025-01-23 02:32","pubTimestamp":1737570762,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日02时32分，Actuate Therapeutics, Inc.股票出现波动，股价快速拉升5.61%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123023243abb4d6e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123023243abb4d6e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ACTU"],"gpt_icon":0},{"id":"2505277554","title":"Actuate Therapeutics, Inc.盘中异动 大幅上涨5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505277554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505277554?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:09","pubTimestamp":1737472197,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时09分，Actuate Therapeutics, Inc.股票出现异动，股价大幅拉升5.57%。Actuate Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.16%。其相关个股中，Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Genelux Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为690.12%、202.93%、171.30%，振幅较大的相关个股有Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Genelux Corporation，振幅分别为92.63%、38.48%、22.36%。Actuate Therapeutics, Inc.公司简介：Actuate Therapeutics Inc是一家临床阶段的生物制药公司，专注于通过抑制糖原合酶激酶3 来开发治疗高影响的、难治的癌症的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121230957960bc140&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121230957960bc140&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACTU","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.actuatetherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.082},{"period":"1month","weight":-0.4471},{"period":"3month","weight":-0.6633},{"period":"6month","weight":-0.6461},{"period":"1year","weight":-0.6638},{"period":"ytd","weight":-0.616}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Actuate Therapeutics, Inc.于2015年1月16日在特拉华州注册成立，名称为Apotheca Therapeutics, Inc.，并于2015年10月1日更名为Actuate Therapeutics, Inc.。该公司是一家临床阶段的生物制药公司，专注于通过抑制糖原合成酶激酶-3（GSK-3）开发治疗高影响、难以治疗的癌症的疗法。他们正在开发elraglusib（前身为9-ING-41），这是一种小分子，旨在进入癌症细胞并阻断GSK-3β酶的功能，GSK-3是复杂生物信号级联的主要调节因子，包括致癌基因介导的信号级联，导致肿瘤细胞存活、生长、迁移和侵袭。","exchange":"NASDAQ","name":"Actuate Therapeutics Inc","nameEN":"Actuate Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Actuate Therapeutics Inc(ACTU)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Actuate Therapeutics Inc(ACTU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Actuate Therapeutics Inc,ACTU,Actuate Therapeutics Inc股票,Actuate Therapeutics Inc股票老虎,Actuate Therapeutics Inc股票老虎国际,Actuate Therapeutics Inc行情,Actuate Therapeutics Inc股票行情,Actuate Therapeutics Inc股价,Actuate Therapeutics Inc股市,Actuate Therapeutics Inc股票价格,Actuate Therapeutics Inc股票交易,Actuate Therapeutics Inc股票购买,Actuate Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Actuate Therapeutics Inc(ACTU)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Actuate Therapeutics Inc(ACTU)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}